This activity is a recording of a live webinar, if you claimed credit for the live activity, you should not claim credit for this activity.
Activity Overview
This dynamic session will explore why pharmacy clinicians and healthcare systems are shifting from race-based estimated glomerular filtration rate (eGFR) for medication-related decision-making. Attendees will gain practical insight into why eGFR, especially when adjusted for individual body surface area, offers greater accuracy than the traditional Cockcroft-Gault method, particularly in patients at the extremes of body size. Through real-world clinical scenarios, participants will also learn how incorporating cystatin C (alone or alongside serum creatinine) enhances precision in eGFR estimation. Join us for a case-based discussion that will empower pharmacists to confidently apply these evolving practices in medication-related decision-making.
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.
This activity was planned to meet the educational needs of pharmacists that estimate kidney function for medication-related decision-making in persons with decreased kidney function.
After completing this activity, the learner should be able to:
Describe the rationale for assessing kidney function using a non-race-based estimated glomerular filtration rate (eGFR) rather than Cockcroft-Gault estimated creatinine clearance (C-G eCrCL).
Apply BSA-adjusted eGFR to medication-related decision-making, given a patient case.
Evaluateclinical indications forincorporating cystatin C into the eGFR calculation for medication-related decisions.
In accordance with our accreditor’s Standards of Integrity and Independence in Accredited Continuing Education, ASHP requires that all individuals in control of content disclose all financial relationships with ineligible companies. An individual has a relevant financial relationship if they have had a financial relationship with an ineligible company in any dollar amount in the past 24 months and the educational content that the individual controls is related to the business lines or products of the ineligible company.
An ineligible company is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The presence or absence of relevant financial relationships will be disclosed to the activity audience.
No one in control of the content of this activity has a relevant financial relationship (RFR) with an ineligible company.
Per ACPE requirements, CPE credit must be claimed within 60 days of being earned. Once you have processed and claimed your CE credit, we encourage you to check your NABP eProfile account to verify your credits were transferred successfully before the ACPE 60-day deadline. It is an electronic direct-report process so your credits should appear in your account within a few minutes. After the 60 day deadline, ASHP will no longer be able to report your credit(s) for this activity.
